3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
188
Neoplasm Metastasis
152
Neoplasms
141
Leukemia, Myeloid, Acute
139
Colorectal Neoplasms
132
Breast Neoplasms
122
Melanoma
96
Ovarian Neoplasms
94
Prostatic Neoplasms
89
Recurrence
88
Multiple Myeloma
84
Lung Neoplasms
78
Pancreatic Neoplasms
77
Glioblastoma
77
Squamous Cell Carcinoma of Head and Neck
75
Lymphoma, Non-Hodgkin
67
Myelodysplastic Syndromes
66
Triple Negative Breast Neoplasms
58
Glioma
58
Stomach Neoplasms
54
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Endometrial Neoplasms
51
Carcinoma, Renal Cell
49
Brain Neoplasms
49
Small Cell Lung Carcinoma
47
Lymphoma, Large B-Cell, Diffuse
46
Carcinoma, Hepatocellular
45
Lymphoma, B-Cell
42
Lymphoma, Follicular
41
Sarcoma
40
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Solitary Fibrous Tumors
×
90 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled